Overview of anal cancer for the surgeon

Surgical Oncology Clinics of North America

Volumn 13, Issue 2, 2004, Pages 249-262

  Rousseau Jr , Dennis L ^a   Petrelli, Nicholas J ^b,c   Kahlenberg, Morton S ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b HELEN F GRAHAM CANCER CENTER   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADENOCARCINOMA; ANUS CANCER; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LUNG TOXICITY; MELANOMA; METASTASIS; NEPHROTOXICITY; PATHOGENESIS; PATHOLOGICAL ANATOMY; RECURRENT CANCER; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SQUAMOUS CELL CARCINOMA; SURGEON; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; WART VIRUS;

ADENOCARCINOMA; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; MELANOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PROGNOSIS;

EID: 2342616748     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2003.12.007     Document Type: Review

References (95)

1. Myerson R.J., Karnell L.H., Menck H.R. The National Cancer Data Base report on carcinoma of the anus. Cancer. 80:1997;805-815
2. Jemal A., Murry T., Samuels A., Gahfoor A., Ward E., Thun M.J. Cancer statistics, 2003. CA Cancer J Clin. 53:2003;5-26
3. Jass J.R., Sobin L.H. Histologic typing of intestinal tumors. World Health Organization. 2nd edition:1989;Springer, New York
4. Beahrs O.H., Henson D.E., Hutter R.P., Kennedy B.J. Manual for staging of cancer. American Joint Committee on Cancer. 4th edition:1992;JB Lippincott, Philadelphia
5. Nivatvongs S., Gordon P.H. Surgical anatomy. Gordon P.H., Nivatvongs S. Principles and practice of surgery for the colon, rectum and anus. 2nd edition:1999;3-39 Quality Medical Publishing, St. Louis, MO
6. Gervasoni J.E., Wanebo H.J. Cancers of the anal canal and anal margin. Cancer Invest. 21:2003;452-464
7. Cummings B.J. The treatment of anal canal cancer. Int J Radiat Oncol Biol Phys. 17:1989;1359-1364
8. Jensen S.L., Hagen K., Shokouh-Amiri M.H., Nielsen O.V. Does an erroneous diagnosis of squamous-cell carcinoma of the anal canal and anal margin at first physician visit influence prognosis? Dis Colon Rectum. 30:1987;345-351
9. Cummings B.J. Anal cancer. Perez C.A., Brady L.J. Principles and practice of radiation oncology. 3rd edition:1998;1511-1524 Lippincott-Raven, Philadelphia
10. Minsky B.D., Hoffman J.P., Kelsen D.P. Cancer of the anal region. DeVita V.T. Jr., Hellman S., Rosenberg S.A. Cancer: principles and practice of oncology. 6th edition:2001;1319-1342 Lippincott, Williams, and Wilkins, Philadelphia
11. Peters R.K., Mack T.M. Patterns of anal carcinoma by gender and marital status in Los Angeles County. Br J Cancer. 48:1983;629-636
12. Daling J.R., Weiss N.S., Hislop T.G., et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med. 317:1987;973-977
13. Daling J.R., Weiss N.S., Klopfenstein L.L., Cochran L.E., Chow W.H., Daifuku R. Correlates of homosexual behavior and the incidence of anal cancer. JAMA. 247:1982;1988-1990
14. Frisch M., Glimelius B., van den Brule A.C., et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 337:1997;1350-1358
15. Palefsky J.M., Holly E.A., Gonzales J., Berline J., Ahn D.K., Greenspan J.S. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res. 51:1991;1014-1019
16. Shroyer K.R., Kim J.G., Manos M.M., Greer C.E., Pearlman N.W., Franklin W.A. Papillomavirus found in anorectal squamous carcinoma, not in colon adenocarcinoma. Arch Surg. 127:1992;741-744
17. Zaki S.R., Judd R., Coffield L.M., Greer P., Rolston F., Evatt B.L. Human papillomavirus infection and anal carcinoma: retrospective analysis by in situ hybridization and the polymerase chain reaction. Am J Pathol. 140:1992;1345-1355
18. Noffsinger A.E., Suzuk L., Hui Y.Z., Gal A.A., Fenoglio-Preiser C.M. Differential sensitivities of E6 type-specific and L1 consensus primers in the detection of human papillomavirus in anal carcinoma. Mod Pathol. 8:1995;509-514
19. Prasad M.L., Abcarian H. Malignant potential of perianal condyloma acuminatum. Dis Colon Rectum. 23:1980;191-197
20. Croxson T., Chabon A.B., Rorat E., Barash I.M. Intraepithelial carcinoma of the anus in homosexual men. Dis Colon Rectum. 27:1984;325-330
21. Friedman H.B., Saah A.J., Sherman M.E., et al. Human papillomavirus, anal squamous intraepithelial lesions, and human immunodeficiency virus in a cohort of gay men. J Infect Dis. 59:1998;45-52
22. Scholefield J.H., Hickson W.G., Smith J.F., Rogers K., Sharp F. Anal intraepithelial neoplasia: part of a multifocal disease process. Lancet. 340:1992;1271-1273
23. Williams G.R., Lu Q.L., Love S.B., Talbot I.C., Northover J.M. Properties of HPV-positive and HPV-negative anal carcinomas. J Pathol. 180:1996;378-382
24. Ryan D.P., Compton C.C., Mayer R.J. Carcinoma of the anal canal. N Engl J Med. 342:2000;792-800
25. Holly E.A., Whittemore A.S., Aston D.A., Ahn D.K., Nickoloff B.J., Kristiansen J.J. Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst. 81:1989;1726-1731
26. Melbye M., Rabkin C., Frisch M., Biggar R.J. Changing patters of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol. 139:1994;772-780
27. Frisch M., Melbye M., Moller H. Trends in incidence of anal cancer in Denmark. BMJ. 306:1993;419-422
28. Melbye M., Cote T.R., Kessler L., Gail M., Biggar R.J. High incidence of anal cancer among AIDS patients. Lancet. 343:1994;636-639
29. Holmes F., Borek D., Owen-Kummer M., et al. Anal cancer in women. Gastroenterology. 95:1988;107-111
30. Daling J.R., Sherman K.J., Hislop T.G., et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol. 135:1992;180-189
31. Penn I. Cancers of the anogenital region in renal transplant recipients: analysis of 65 cases. Cancer. 58:1986;611-616
32. Arends M.J., Benton E.C., McLaren K.M., Stark L.A., Hunter J.A., Bird C.C. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy. Br J Cancer. 75:1997;722-728
33. Adami J., Gäbel H., Lindelöf B., et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer. 89:2003;1221-1227
34. Frisch M., Olsen J.H., Bautz A., Melbye M. Benign anal lesions and the risk of anal cancer. N Engl J Med. 331:1994;300-302
35. Greenall M.J., Quan S.H., Decoss J. Epidermoid cancer of the anus. Br J Surg. 72:1985;S97-S103
36. Roseau G., Palazzo L., Colardelle P., Chaussade S., Couturier D., Paolaggi J.A. Endoscopic ultrasonography in the staging and follow-up of epidermoid carcinoma of the anal canal. Gastrointest Endosc. 40:1994;447-450
37. Goldman S., Glimelius B., Norming U., Pahlman L., Seligson U. Transanorectal ultrasonography in anal carcinoma: a prospective study of 21 patients. Acta Radiol. 29:1988;337-341
38. Perera D., Pathma-Nathan N., Rabbitt P., Hewett P., Reiger N. Sentinel node biopsy for squamous-cell carcinoma of the anus and anal margin. Dis Colon Rectum. 46:2003;1027-1031
39. Stearns M.W., Urmacher C., Sternberg S.S. Cancer of the anal canal. Curr Probl Cancer. 4:1980;1-44
40. Clark J., Petrelli N., Herrera L., Mittelman A. Epidermoid carcinoma of the anal canal. Cancer. 57:1986;400-406
41. Pyper P.C., Parks T.G. The results of surgery for epidermoid carcinoma of the anus. Br J Surg. 72:1985;712-714
42. Esiashvili N., Landry J., Matthews R.H. Carcinoma of the anus: strategies in management. Oncologist. 7:2002;188-199
43. Greene F.L., Page D.L., Fleming I.D., et al. AJCC cancer staging handbook. 6th edition:2002;Springer, New York
44. Boman B.M., Moertel C.G., O'Connell M.J., et al. Carcinoma of the anal canal: a clinical and pathologic study of 188 cases. Cancer. 54:1984;114-125
45. Pintor M.P., Northover J.M., Nicholls R.J. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984. Br J Surg. 76:1989;806-810
46. Schraut W.H., Wang C.H., Dawson P.J., Block G.E. Depth of invasion, location, and size of cancer of the anus dictate operative treatment. Cancer. 51:1983;1291-1296
47. Dougherty B.G., Evans H.L. Carcinoma of the anal canal: a study of 79 cases. Am J Clin Pathol. 83:1985;159-164
48. Al-Jurf A.S., Turnbull R.B., Fazio V.W. Local treatment of squamous cell carcinoma of the anus. Surg Gynecol Obstet. 148:1979;576-578
49. Singh R., Nime F., Mittelman A. Malignant epithelial tumors of the anal canal. Cancer. 48:1981;411-415
50. Touboul E., Schlienger M., Buffat L., et al. Epidermoid carcinoma of the anal canal: results of curative-intent radiation therapy in a series of 270 patients. Cancer. 73:1994;1569-1579
51. Hughes L.L., Rich T.A., Delclos L., Ajani J.A., Martin R.G. Radiotherapy for anal cancer: experience from 1979-1987. Int J Radiat Oncol Biol Phys. 21:1991;1115-1125
52. Eschwege F., Lasser P., Chavy A., et al. Squamous cell carcinoma of the anal canal: treatment by external beam irradiation. Radiother Oncol. 3:1985;145-150
53. Constantinou E.C., Daly W., Fung C.Y., Willett C.G., Kaufman D.S., DeLaney T.F. Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys. 39:1997;651-657
54. Cummings B.J., Keane T.J., O'Sullivan B., Wong C.S., Catton C.N. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys. 21:1991;1115-1125
55. Allal A.S., Mermillod B., Roth A.D., Marti M.C., Kurtz J.M. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. Int J Radiat Oncol Biol Phys. 39:1997;1099-1105
56. Moore H.G., Guillem J.G. Anal neoplasms. Surg Clin N Am. 82:2002;1233-1251
57. Mitchell S.E., Mendenhall W.M., Zlotecki R.A., Carroll R.R. Squamous cell carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 49:2001;1007-1013
58. Nigro N.D., Vaitkevicius V.K., Considine B. Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 17:1974;354-356
59. Koness J., Wanebo H.J. Anal canal cancer: multimodality therapy. Wanebo H.J. Surgery for gastrointestinal cancer: a multidisciplinary approach. 1997;727 Lippincott-Raven, Philadelphia
60. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 15:1997;2040-2049
61. UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet. 348:1996;1049-1054
62. Sheldon R., Slaughter D. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma. Cancer. 58:1986;1428-1436
63. Chang A.Y., Kuebler J.P., Pandya K.J., Israel R.H., Marshall B.C., Tormey D.C. Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoids. Cancer. 57:1986;2285-2290
64. Verweij J., van Zanten T., Souren T., Golding R., Pinedo H.M. Prospective study on the dose relationship of mitomycin C-induced interstitial pneumonitis. Cancer. 60:1987;756-761
65. Kantarjian H.M., Keating M.J., Walters R.S., et al. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol. 4:1986;1748-1757
66. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 14:1996;2527-2539
67. Ajani J.A., Carrasco C.H., Jackson D.E., Wallace S. Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal. Am J Med. 87:1989;221-224
68. Mahjoubi M., Sadek H., Fancois E., et al. Epidermoid anal canal carcinoma: activity of cisplatin and continuous 5-fluorouracil in metastatic and/or local recurrent disease. Proc Am Soc Clin Oncol. 9:1990;114a
69. Doci R., Zucali R., La Monica G., et al. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. J Clin Oncol. 14:1996;3121-3125
70. Paleologo F.P., Goswitz M.S., Skibber J.M., et al. Results of radiation and concomitant continuous infusion 5-fluorouracil and cisplatin for anal cancer. Int J Radiat Oncol Biol Phys. 39:(Suppl):1997;202
71. Rich T.A., Ajani J.A., Morrison W.H., Ota D., Levin B. Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother Oncol. 27:1993;209-215
72. Hung A., Crane C., Delclos M., Ballo M., Ajani L., Lin E. Cisplatin-based combined modality therapy for anal carcinoma. Cancer. 97:2003;1195-1202
73. Martenson J.A., Lipsitz S.R., Wagner H. Jr., et al. Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys. 35:1996;745-749
74. Peiffert D., Seitz J.F., Rougier P., et al. Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study. Ann Oncol. 8:1997;575-581
75. Wolfe H.R.I. The management of metastatic inguinal adenitis in epidermoid carcinoma of the anus. Proc R Soc Med. 61:1961;626-631
76. Greenall M.J., Magill G., Quan S.H.Q. Recurrent epidermoid carcinoma of the anus. Cancer. 57:1986;1437-1441
77. Cleator S., Fife K., Nelson M., Gazzard B., Phillips R., Bower M. Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer. 36:2000;754-758
78. Holland J.M., Swift P.S. Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy. Radiology. 193:1994;251-254
79. Peddada A.V., Smith D.E., Rao A.R., Frost D.B., Kagan A.R. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 37:1997;1101-1105
80. Hoffman R., Welton M.L., Klencke B., Weinberg V., Krieg R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys. 44:1999;127-131
81. Pocard M., Tiret E., Nugent K., Dehni N., Parc R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum. 41:1998;1488-1493
82. Allal A.S., Laurencet F.M., Reymond M.A., Kurtz J.M., Marti M.C. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer. 86:1999;405-409
83. Van der Wal B.C., Cleffken B.I., Gulec B., Kaufman H.S., Choti M.A. Results of salvage abdominoperineal resection for recurrent anal carcinoma following combined chemoradiation therapy. J Gastrointest Surg. 5:2001;383-387
84. Papagikos M., Crane C.H., Skibber J., et al. Chemoradiation for adenocarcinoma of the anus. Int J Radiat Oncol Biol Phys. 55:2003;669-678
85. Abel M.E., Chiu Y.S., Russell T.R., Volpe P.A. Adenocarcinoma of the anal glands: results of a survey. Dis Colon Rectum. 36:1993;383-387
86. Klas J.V., Rothenberger D.A., Wong W.D., Madoff R.D. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer. 85:1999;1686-1693
87. Ward M.W., Romano G., Nicholls R.J. The surgical treatment of anorectal malignant melanoma. Br J Surg. 73:1986;68-69
88. Brady M.S., Kavolius J.P., Quan S.H. Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum. 38:1995;146-151
89. Chiu Y.S., Unni K.K., Beart R.W. Jr. Malignant melanoma of the anorectum. Dis Colon Rectum. 23:1980;122-124
90. Weinstock M.A. Epidemiology and prognosis of anorectal melanoma. Gastroenterology. 104:1993;174-178
91. Thibault C., Sagar P., Nivatvongs S., Ilstrup D.M., Wolff B.G. Anorectal melanoma: an incurable disease? Dis Colon Rectum. 40:1997;661-668
92. Bullard K.M., Tuttle T.M., Rothenberger D.A., et al. Surgical therapy for anorectal melanoma. J Am Coll Surg. 196:2003;206-211
93. Baron J.M., Heise R., Merk H.F., Abuzahra F. Current and future directions in the treatment of metastatic malignant melanoma. Curr Med Chem Anticancer Agents. 3:2003;393-398
94. Boasberg P.D., O'Day S.J., Kristedja T.S., et al. Biochemotherapy for metastatic melanoma with limited central nervous system involvement. Oncology. 64:2003;328-335
95. Agarwala S. Improving survival in patients with high-risk and metastatic melanoma: immunotherapy leads the way. Am J Clin Dermatol. 4:2003;333-346